Comparison of Different Regimens of Magnesium Sulphate in Patients With Severe Preeclampsia in Ain Shams University Maternity Hospital (Retrospective Cohort)

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The goal of this observational study is to learn about the effects of the different drug regimens of magnesium sulphate in treatment of (severe pre-eclampsia). This condition affects some pregnant women and raises their blood pressure. It may also cause seizures (fits). The medication (magnesium sulphate) helps to prevent seizures. The main question this study aims to answer is: What are the different regimens of magnesium sulphate that are used to prevent seizures in pregnant women with severe pre-eclampsia? Participants already have taken the magnesium sulphate as part of their regular medical care for severe pre-eclampsia. Researchers will look into the records of the participants in the past 5 years to collect the data.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• All hospital records of patients diagnosed as preeclampsia with severe features planned to receive magnesium sulphate.

Locations
Other Locations
Egypt
Ain Shams University Maternity Hospital
RECRUITING
Cairo
Contact Information
Primary
Rania HM Ahmed, MD
raneyah@med.asu.edu.eg
20201200522444
Backup
Sherif Ashoush, MD
sherifashoush@med.asu.edu.eg
Time Frame
Start Date: 2024-12-03
Estimated Completion Date: 2026-03
Participants
Target number of participants: 400
Treatments
pregnant women with severe preeclampsia
Preeclampsia with severe hypertension that does not respond to treatment or is associated with ongoing or recurring severe headaches, visual scotomata, nausea or vomiting, epigastric pain, oliguria, and severe hypertension, as well as progressive deterioration in laboratory blood tests such as rising creatinine or liver transaminases or falling platelet count, or failure of fetal growth or abnormal doppler findings.
Related Therapeutic Areas
Sponsors
Leads: Ain Shams Maternity Hospital

This content was sourced from clinicaltrials.gov